TEKINJECT
Board
2 directors, no change since 2024Director (not named in the articles)
appointed by deed of 03-04-2023
term without a fixed end
listed in the 2025 annual accounts, filed on 19-06-2026
LIVIAM BV
Additional director, permanent representative Vandermeulen Annelies
appointed by deed of 10-12-2024
term without a fixed end
listed in the 2025 annual accounts, filed on 19-06-2026
- Signing authorityThe articles say who may bind the company, for example by signing a contract.
- Each director alonedeed of 03-04-2023
Permanent representatives 1
Mandates through the years
2 names, the dashed line is todayISKE Brian
Director (not named in the articles)
Director (not named in the articles)
LIVIAM
Additional director
Additional director
Board
Mandates as a list
- ISKE Brian
- Director (not named in the articles), from 30-03-2023 to date
- LIVIAM
- Additional director, appointed by deed of 10-12-2024, still in office
Control
Shareholder
Equity €89,040
Profit €52,196 in 2025 (profit €10,193 in 2024)
Checked score 69
Source: accounts LIVIAM 2025
36%
This company
TEKINJECT
Equity €391,743
Profit €136,218 in 2025
Capital
- Contribution
- €200,000
- Shares
- 1,000
- Contribution per share
- €200
- Equity per share
- €392 in 2025
- Source
- deed of 03-04-2023
Articles of association
deed of 03-04-2023 (in Dutch)- DurationMost companies exist for an unlimited period, until they are dissolved.
- Unlimited
- Statutory auditorA statutory auditor is a registered auditor who checks the annual accounts. Small companies need not have one. According to the deed, the legal criteria do not require one here.
- No statutory auditor
Capital transactions
Shareholders according to the deeds
At incorporation
deed of 03-04-2023 ↗
- Ambel Group Inc (BE 0799.918.121) 1,000 shares (100%) · €200,000
Capital over time
- 03-04-2023 Incorporation · €200,000 · 1,000 shares